{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Aceragen, Inc."},"Symbol":{"label":"Symbol","value":"ACGN"},"Address":{"label":"Address","value":"505 EAGLEVIEW BOULEVARD SUITE 212, EXTON, Pennsylvania, 19341, United States"},"Phone":{"label":"Phone","value":"+1 484 348-1600"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Aceragen Inc is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases. The company&nbsp;portfolio includes late-stage programs based on well-established biological principles that are developing to be innovative therapeutics capable of addressing the unmet medical needs of individuals living with rare diseases."},"CompanyUrl":{"label":"Company Url","value":"https://www.iderapharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"John Clayton Taylor","title":"President, Chief Executive Officer &amp; Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}